Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...

At the RP2D and maximum tolerated dose (100 µg,) cemsidomide achieved a 53% overall response rate (ORR). At the 75 µg dose level, cemsidomide achieved a 40% ORR. Across all doses evaluated, ...

Updated ELVN-001 results showed strong molecular response rates in previously treated CML patients, while the FDA aligned ...

Shattuck Labs (STTK) maintains a 'Hold' rating as SL-325 advances with promising phase 1 immunogenicity and PK data in healthy volunteers.

Phase One, a leading developer of digital imaging technologies, has announced the successful launch and orbital deployment of an imaging sensor based on the Phase One iXM Series 150MP frame camera.

President Donald Trump, joined by Chinese Vice Premier Liu He, sign the U.S.-China Phase One trade agreement in 2020. (White House photo) Farm organizations are warning the Trump administration that ...

Huntsman Cancer Institute at the University of Utah stands at the forefront of innovative cancer research and treatment. Phase 1 clinical trials are key to finding better ways to treat cancer safely ...

Phase 1B/2A safety, pharmacokinetics and pharmacodynamics study of fosciclopirox alone and in combination with cytarabine in patients with relapsed/refractory acute myeloid leukemia. This is an ASCO ...